Vasoplegia During Cardiac Surgery: Current Concepts and Management (Q37811135)

23 August 2017

title

Vasoplegia during cardiac surgery: current concepts and management (English)

1 reference

23 August 2017

Vasoplegia During Cardiac Surgery: Current Concepts and Management (English)

1 reference

Crossref

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

31 August 2024

0 references

1 reference

Gregory W. Fischer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21092891

31 August 2024

Mathew A. Levin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21092891

31 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21092891

31 August 2024

publication date

1 January 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S104306791000081X?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

https://api.elsevier.com/content/article/PII:S104306791000081X?httpAccept=text/plain

31 August 2024

1 reference

Crossref

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Seminars in thoracic and cardiovascular surgery

31 August 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

140-144

1 reference

Systemic inflammatory response syndrome after cardiac operations.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Vasoplegic syndrome--the role of methylene blue

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

The pathogenesis of vasodilatory shock

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

High-dose vasopressin is not superior to norepinephrine in septic shock*

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

NO., CO and .OH. Endogenous soluble guanylyl cyclase-activating factors

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

Spurious pulse oximetry with intrauterine methylene blue injection.

31 August 2024

1 reference

https://api.crossref.org/works/10.1053/J.SEMTCVS.2010.09.007

31 August 2024

Identifiers

1 reference

23 August 2017

1 reference